학술논문
The Long-Term Effectiveness of Sacral Neuromodulation in Treating Low Anterior Resection Syndrome: A Single Center Experience
RESEARCH ARTICLE
RESEARCH ARTICLE
Document Type
Report
Source
Turkish Journal of Colorectal Disease. September 2023, Vol. 33 Issue 3, p75, 8 p.
Subject
Language
English
ISSN
2536-4898
Abstract
Introduction During the past decades, there have been remarkable improvements in the treatment of rectal cancer with the widespread adoption of total mesorectal excision and neoadjuvant chemoradiotherapy (CRT) regimens, which [...]
Aim: Sacral neuromodulation (SNM) has emerged as an effective treatment option for patients with fecal incontinence (FI). The efficacy of SNM in the treatment of low anterior resection syndrome (LARS) following rectal cancer surgery is encouraging. The aim of this study is to review the long-term outcomes of patients treated with SNM for LARS. Method: A review of a prospectively maintained database of consecutive SNM procedures for LARS between June 2017 and June 2020 was conducted. Bowel habits diaries, the Cleveland Clinic Florida-Fecal Incontinence Score (CCF-FIS), the Fecal Incontinence Quality of Life (FIQoL) scale, and the LARS score were evaluated at baseline, 3 months, and 24 months after definitive SNM implantation. Results: The study included 14 patients; 11 were males, and the mean age was 59.2 ([+ or -]10.2). Thirteen patients underwent permanent implantation of the SNM device. The mean score of FI episodes was reduced from 16 to 4 (p Conclusion: SNM improves bowel dysfunction and QoL in patients with LARS following rectal cancer surgery and maintains its effectiveness over time. Keywords: Sacral neuromodulation, low anterior resection syndrome, rectal cancer
Aim: Sacral neuromodulation (SNM) has emerged as an effective treatment option for patients with fecal incontinence (FI). The efficacy of SNM in the treatment of low anterior resection syndrome (LARS) following rectal cancer surgery is encouraging. The aim of this study is to review the long-term outcomes of patients treated with SNM for LARS. Method: A review of a prospectively maintained database of consecutive SNM procedures for LARS between June 2017 and June 2020 was conducted. Bowel habits diaries, the Cleveland Clinic Florida-Fecal Incontinence Score (CCF-FIS), the Fecal Incontinence Quality of Life (FIQoL) scale, and the LARS score were evaluated at baseline, 3 months, and 24 months after definitive SNM implantation. Results: The study included 14 patients; 11 were males, and the mean age was 59.2 ([+ or -]10.2). Thirteen patients underwent permanent implantation of the SNM device. The mean score of FI episodes was reduced from 16 to 4 (p Conclusion: SNM improves bowel dysfunction and QoL in patients with LARS following rectal cancer surgery and maintains its effectiveness over time. Keywords: Sacral neuromodulation, low anterior resection syndrome, rectal cancer